Infothek

10.09.2020 Active environmental protection with renewable energies at the Aenova site in Cornu
04.09.2020 New Head of Global Operational Excellence at Aenova Group
23.07.2020 New VP Commercial Excellence at Aenova Group
15.07.2020 New Head of Business Development & Strategy at Aenova Group
08.06.2020 New Managing Director Site Wolfratshausen
05.06.2020 New Managing Director Site Bad Aibling
04.06.2020 New Managing Director Site Sisseln
22.05.2020 New Vice President Corporate HSES at Aenova Group
19.05.2020 New Head of Development Services at Aenova Group
media_press
Infothek
Back

Newsticker

The news ticker provides up-to-date press releases and company information for reading or downloading.
13.10.2020

Aenova expands production capacities at the Tittmoning site

Tittmoning, 13 October 2020. On the company site of Dragenopharm Apotheker Püschl GmbH, member of the Aenova Group, a new production building is under construction. The production capacity of the site can thus be increased to over 10 billion tablets per year. The investment of about € 25 million lays the cornerstone for more than 100 new jobs and is part of further investment projects of the Aenova Group.

15.09.2020

Facing Strong Headwinds. Statement Aenova Group in CHEManager International

Under the title "Facing Strong Headwinds", CHEManager International presents a survey in the pharmaceutical industry, including CDMOs, on the subject, what in their opinion are the most important lessons learned so far working under pandemic conditions, and how will the current pharma business model change in the post-Covid era.

Jan Kengelbach, CEO Aenova Group, summarizes three essential points there.

Read more: “Facing Strong Headwinds” –  published in CHEManager International

10.09.2020

Active environmental protection with renewable energies at the Aenova site in Cornu

More sustainable production thanks to new photovoltaic system

Active environmental protection with renewable energies: the SWISSCAPS Romania plant of #AenovaGroup in Cornu, specialist for the production and packaging of soft gel capsules with vegan or gelatin shell, will produce around 425 MWh per year with the new photovoltaic system on the roof of the hall. 

https://bit.ly/2F7ywaw (Video of ENGIE Romania in Romanian language)

04.09.2020

New Head of Global Operational Excellence at Aenova Group

David Hitchcock is the new Head of Global Operational Excellence at Aenova Group: "Looking forward to working with the teams across our sites to drive performance and grow the continuous improvement mindset and culture through our Aenova Manufacturing System."

03.08.2020

Haupt Pharma Wülfing, member of the Aenova group, modernizes the building for pharmaceutical development

Gronau, July 2020 - Quality and safety are the central issues in pharmaceutical development and production. This also applies, of course, to buildings and their infrastructure. Haupt Pharma Wülfing GmbH, a member of the Aenova Group with more than 4,300 employees worldwide and about 450 employees in Gronau, has now put the modernized development building back into operation.

23.07.2020

New VP Commercial Excellence at Aenova Group

Dr. Volker Viktor is the new Vice President Commercial Excellence at Aenova Group: „In everything we do, we always focus strictly on the value we can achieve for our customers!”

15.07.2020

New Head of Business Development & Strategy at Aenova Group

Dr. Matthias Groh ist the new head of Business Development & Strategy at Aenova Group: "Aenova’s broad technological offering and international footprint uniquely positions it to supply accessible and innovative medicines globally."

09.07.2020

Aenova presents new organizational structure of the group

The Aenova Group announces the company's new organizational structure: with the three new business units Solids, Semi Solids & Liquids and Softgel Capsules, the company's 15 manufacturing sites will be organized to focus on the business areas with high growth potential.

08.06.2020

New Managing Director Site Wolfratshausen

Dr. Franz Clementschitsch is the new Managing Director at the Site Wolfratshausen: „Looking forward to driving Quality, Delivery Reliability, Service Excellence and Continuous Improvement together with my team and continue to create value for our customers!” 

05.06.2020

New Managing Director Site Bad Aibling

Thomas Lemke is the new Managing Director at the Site Bad Aibling: „Quality, Delivery Reliability, Service Excellence and Continuous Improvement are important parameters – that is our ambition at Aenova.”

04.06.2020

New Managing Director Site Sisseln

Fridrik Thorsteinsson is the new Managing Director at the Site Sisseln: „We are proud to offer a 100% carbon-neutral manufacturing footprint and to be a highly reliable partner to our Aenova-customers providing cost-competetive quality solutions.”

 

03.06.2020

In COVID-19 times: Haupt Pharma Amareg produces disinfectant for the city of Regensburg

Haupt Pharma Amareg GmbH, member of the Aenova Group, has been supporting the city of Regensburg with disinfectants since the beginning of the corona crisis. Since March 2020, 12,000 litres have already been delivered.

27.05.2020

COVID-19: Start of Phase 2 clinical trial of IMU-838

Immunic Therapeutics has received approval from German Health Authority (BfArM) to start a phase 2 clinical trial with its selective oral DHODH inhibitor IMU-838 for treatment of  COVID-19. We at the Aenova Group are grateful about the opportunity to participate in the development of the drug and supply of the material for the clinical study.

22.05.2020

New Vice President Corporate HSES at Aenova Group

Dr Pedro Diaz Kraus is the new Vice President Corporate HSES at Aenova Group: „At Aenova we care for our customers and our employees in matters of Health and Safety as well as maintaining high Environmental and Sustainability standards for our products, processes and plants.”

19.05.2020

New Head of Development Services at Aenova Group

Dr. Jörg Gampfer is the new head of development services at Aenova Group: „We offer a high level of quality and efficiency throughout all the stages of product development and manufacturing – that´s the Aenova approach.”

12.05.2020

Angelo Gatto leaves Aenova Group

Angelo Gatto, Senior Vice President Global Sales & Marketing of the Aenova Group, is leaving the company at his own request.

28.04.2020

CMO Leadership Awards: Aenova wins prizes in 3 categories

Renowed Life Science Leader´s CMO Leadership Award recognized the leading contract manufacturing organizations

30.03.2020

COVID-19 Update March 2020

As we are navigating through an unprecedented global crisis, we would like to inform you what the Aenova Group is doing to manage through the COVID-19 pandemic.

02.03.2020

Aenova Group successfully completes refinancing

The Aenova Group, one of the world’s largest Contract and Development Manufacturing Organisations (CDMO) to the pharmaceutical industry, announced today that it has successfully completed the refinancing of its capital structure.

17.07.2019

Aenova Group appoints new CEO

The Supervisory Board of the Aenova Group, one of the world's leading providers of contract pharmaceutical manufacturing and development services, has appointed Jan Kengelbach as the company's new CEO.

17.09.2018

Mohammad Naraghi leaves Aenova Group

Dr Mohammad Naraghi, CEO of Aenova Group, is leaving the company as of September 17. Jan Kengelbach will take on the tasks of CEO on an interim basis until a successor is found.

16.11.2017

Aenova Group implements new manufacturing facility in Italy

The Aenova Group expands its Animal Health production with a new dedicated manufacturing area for solids veterinary pharmaceuticals in Latina (Italy). 

06.09.2017

Aenova Group expands site in Cornu, Romania

The Aenova Group, one of the world's leading corporations in the pharmaceutical and healthcare industry, is significantly increasing its production capacity for soft gelatin capsules. The company is investing around 14 million euros into the expansion of its site in Cornu, Romania and will create almost 100 new jobs.

11.08.2016

SPD-politician visits Aenova in Gronau

Federal Minister of Labour and Social Affairs, Andrea Nahles, received detailed information about high-quality pharmaceutical contract manufacturing „Made in Germany“ at the Aenova Group in Gronau (Lower Saxony). Together with the mayor of the municipality Gronau, Rainer Mertens, the minister visited the Lower Saxony site of Aenova, a worldwide leading company of the pharma- and healthcare-industry.

18.05.2016

Aenova Group enlarges management team

The Supervisory Board of the Aenova Holding has appointed Mohammad Naraghi, M.D., Sc.D. (51) to the position of Chief Executive Officer (CEO) effective as of 15 May 2016. He will be responsible for Strategy, Marketing and Distribution as well as Research and Development, Communications, Quality and Human Resources. The Supervisory Board appointed Marco Robert Gorgas (45) as the new Chief Operating Officer (COO). From 1 June 2016, he will be in charge of Production and Supply Chain Management.

10.12.2015

Marine Ingredients Acquires Softgel Production Facility

Aenova Group announced today that it has signed a definitive agreement to sell Swiss Caps USA’s softgel manufacturing facility in Miami, FL, to Marine Ingredients, a leading omega-3 manufacturer. As part of the agreement, the employees currently working in Miami will transfer from Swiss Caps USA to Innova Softgel, LLC, a newly formed subsidiary of Marine Ingredients. Both parties agreed not to disclose financial details of the transaction, which is expected to be closed by the end of December.

06.10.2015

Aenova Group initiates restructuring of its management team

The Aenova Group, one of the world’s leading providers of contract manufacturing and development services to the pharmaceutical industry, has begun restructuring its management team.

24.11.2014

Further acquisitions enhance the Aenova Group’s portfolio

The Aenova Group, one of the world’s largest pharmaceutical contract manufacturers, has successfully strengthened and developed its leading position on the European market by merging with Haupt Pharma at the beginning of the year. 
According to Heiner Hoppmann, the CEO of the Aenova Group, the organisation has now reached its necessary size and will focus primarily on qualitative growth over the next few years. 

18.10.2013

Combining together on the road to success: Aenova and Haupt Pharma

The Aenova Group, one of the leading companies in the pharmaceutical and healthcare industry, is continuing its successful period of growth. As Aenova has already announced, it has found in Haupt Pharma, a company specializing in contract development and manufacturing for the pharmaceutical industry, a partner which will help it achieve a strategic expansion of its portfolio.

10.10.2013

Aenova Group at the CPhI expo 2013

Aenova will be exhibiting at the CPhI Worldwide in Frankfurt from October 22 to 24, 2013. The CPhI (Convention on Pharmaceutical Ingredients) is the most important exhibition for the chemical and pharmaceutical processing industries and one of the largest pharmaceutical trade fairs in the world.

25.04.2013

The Aenova Group's growth continues

With an increase in turnover of around three percent from € 262 million in 2011 to € 269 million in 2012, the Aenova Group further extended its market presence in 2012.

07.02.2013

Successful integration

Successful integration as top managers from the Temmler Group join the Aenova management team in 2012.

06.12.2012

Takeover of Euro Vital Pharma by the Aenova Group

The Aenova Group, one of the leading companies in the global pharmaceutical and healthcare industry, is taking over Euro Vital Pharma GmbH & Co. KG as part of its ongoing growth strategy.

30.10.2012

Takeover of the Temmler Group by the Aenova Group

The Aenova Group, one of the leading companies in the global pharmaceutical and healthcare industry, is in the process of taking over the Temmler Group.

09.10.2012

Aenova remains on track for expansion

The Aenova Group, one of the world’s leading companies in the pharmaceutical and healthcare industry, is presenting its extensive portfolio of services and its most recent innovations at CPhI in Madrid. Alongside Aenova’s comprehensive fullservice offering in the field of pharmaceutical development, the focus will also be on its enhanced expertise in multiple-unit pellet systems (MUPS) and the development and manufacturing of effervescent products at its Bad Aibling site.

17.09.2012

Sabine Tedden is appointed HR director of Aenova

The Aenova Group has appointed Sabine Tedden as the new head of its HR department with immediate effect.